8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Mar 8, 2024 · 2y ago · Accession 0001193125-24-062878
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Amylyx Pharmaceuticals, Inc.
- Ticker
- AMLX
- CIK
- 1658551
- Form type
- 8-K
- Filing date
- Mar 8, 2024
- Report date
- Mar 8, 2024
- Document
- d787565d8k.htm
- Size
- 190 KB